These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 33893377)
1. Myoinositol plus α-lactalbumin supplementation, insulin resistance and birth outcomes in women with gestational diabetes mellitus: a randomized, controlled study. D'Anna R; Corrado F; Loddo S; Gullo G; Giunta L; Di Benedetto A Sci Rep; 2021 Apr; 11(1):8866. PubMed ID: 33893377 [TBL] [Abstract][Full Text] [Related]
2. Effect of inositol stereoisomers at different dosages in gestational diabetes: an open-label, parallel, randomized controlled trial. Fraticelli F; Celentano C; Zecca IA; Di Vieste G; Pintaudi B; Liberati M; Franzago M; Di Nicola M; Vitacolonna E Acta Diabetol; 2018 Aug; 55(8):805-812. PubMed ID: 29774465 [TBL] [Abstract][Full Text] [Related]
3. Effect of dietary myo-inositol supplementation on the insulin resistance and the prevention of gestational diabetes mellitus: study protocol for a randomized controlled trial. Asimakopoulos G; Pergialiotis V; Anastasiou E; Antsaklis P; Theodora M; Vogiatzi E; Kallergi A; Sindos M; Loutradis D; Daskalakis G Trials; 2020 Jul; 21(1):633. PubMed ID: 32646482 [TBL] [Abstract][Full Text] [Related]
4. Myo-inositol Supplementation for Prevention of Gestational Diabetes in Obese Pregnant Women: A Randomized Controlled Trial. D'Anna R; Di Benedetto A; Scilipoti A; Santamaria A; Interdonato ML; Petrella E; Neri I; Pintaudi B; Corrado F; Facchinetti F Obstet Gynecol; 2015 Aug; 126(2):310-315. PubMed ID: 26241420 [TBL] [Abstract][Full Text] [Related]
5. Effects of myo-inositol plus alpha-lactalbumin in myo-inositol-resistant PCOS women. Montanino Oliva M; Buonomo G; Calcagno M; Unfer V J Ovarian Res; 2018 May; 11(1):38. PubMed ID: 29747700 [TBL] [Abstract][Full Text] [Related]
6. Effect of dietary myo-inositol supplementation on the insulin resistance and the prevention of gestational diabetes mellitus: an open-label, randomized controlled trial. Asimakopoulos G; Pergialiotis V; Antsaklis P; Theodora M; Loutradis D; Daskalakis G Arch Gynecol Obstet; 2024 Oct; 310(4):1895-1903. PubMed ID: 39141124 [TBL] [Abstract][Full Text] [Related]
7. The effect of myo-inositol supplementation on the prevention of gestational diabetes in overweight pregnant women: a randomized, double-blind, controlled trial. Esmaeilzadeh S; Ghadimi R; Mashayekh-Amiri S; Delavar MA; Basirat Z Minerva Obstet Gynecol; 2023 Aug; 75(4):357-364. PubMed ID: 35686634 [TBL] [Abstract][Full Text] [Related]
8. Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: a secondary analysis from 3 RCTs. Santamaria A; Alibrandi A; Di Benedetto A; Pintaudi B; Corrado F; Facchinetti F; D'Anna R Am J Obstet Gynecol; 2018 Sep; 219(3):300.e1-300.e6. PubMed ID: 29859136 [TBL] [Abstract][Full Text] [Related]
9. Effect of dietary myo-inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. Matarrelli B; Vitacolonna E; D'Angelo M; Pavone G; Mattei PA; Liberati M; Celentano C J Matern Fetal Neonatal Med; 2013 Jul; 26(10):967-72. PubMed ID: 23327487 [TBL] [Abstract][Full Text] [Related]
10. Potential role and therapeutic interests of myo-inositol in metabolic diseases. Croze ML; Soulage CO Biochimie; 2013 Oct; 95(10):1811-27. PubMed ID: 23764390 [TBL] [Abstract][Full Text] [Related]
11. The effects of a combined intervention (docosahexaenoic acid supplementation and home-based dietary counseling) on metabolic control in obese and overweight pregnant women: the MIGHT study. Garmendia ML; Casanello P; Flores M; Kusanovic JP; Uauy R Am J Obstet Gynecol; 2021 May; 224(5):526.e1-526.e25. PubMed ID: 33152314 [TBL] [Abstract][Full Text] [Related]
12. Influence of myo-inositol on metabolic status for gestational diabetes: a meta-analysis of randomized controlled trials. Chen H; Xiong J; Li Z; Chen Y; Zhang M; Chen D; Liu B J Matern Fetal Neonatal Med; 2024 Dec; 37(1):2228450. PubMed ID: 39115013 [TBL] [Abstract][Full Text] [Related]
13. The influence of different inositol stereoisomers supplementation in pregnancy on maternal gestational diabetes mellitus and fetal outcomes in high-risk patients: a randomized controlled trial. Celentano C; Matarrelli B; Pavone G; Vitacolonna E; Mattei PA; Berghella V; Liberati M J Matern Fetal Neonatal Med; 2020 Mar; 33(5):743-751. PubMed ID: 30558466 [No Abstract] [Full Text] [Related]
14. The effect of combined inositol supplementation on maternal metabolic profile in pregnancies complicated by metabolic syndrome and obesity. Ferrari F; Facchinetti F; Ontiveros AE; Roberts RP; Saade MM; Blackwell SC; Sibai BM; Refuerzo JS; Longo M Am J Obstet Gynecol; 2016 Oct; 215(4):503.e1-8. PubMed ID: 27255472 [TBL] [Abstract][Full Text] [Related]
16. Myo-Inositol for the Prevention of Gestational Diabetes Mellitus. A Brief Review. D'Anna R; Santamaria A; Alibrandi A; Corrado F; DI Benedetto A; Facchinetti F J Nutr Sci Vitaminol (Tokyo); 2019; 65(Supplement):S59-S61. PubMed ID: 31619648 [TBL] [Abstract][Full Text] [Related]
17. Positive effect of a new supplementation of vitamin D Bezerra Espinola MS; Bilotta G; Aragona C Gynecol Endocrinol; 2021 Mar; 37(3):251-254. PubMed ID: 32367738 [TBL] [Abstract][Full Text] [Related]
18. Effect of the treatment with myo-inositol plus folic acid plus melatonin in comparison with a treatment with myo-inositol plus folic acid on oocyte quality and pregnancy outcome in IVF cycles. A prospective, clinical trial. Rizzo P; Raffone E; Benedetto V Eur Rev Med Pharmacol Sci; 2010 Jun; 14(6):555-61. PubMed ID: 20712264 [TBL] [Abstract][Full Text] [Related]
20. A pilot study of D-chiro-inositol plus folic acid in overweight patients with type 1 diabetes. Maurizi AR; Menduni M; Del Toro R; Kyanvash S; Maggi D; Guglielmi C; Pantano AL; Defeudis G; Fioriti E; Manfrini S; Pozzilli P Acta Diabetol; 2017 Apr; 54(4):361-365. PubMed ID: 28039583 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]